1. Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation. Issue 5 (September 2021) Authors: Bernard-Valnet, Raphael; Perriot, Sylvain; Canales, Mathieu; Pizzarotti, Beatrice; Caranzano, Leonardo; Castro-Jiménez, Mayté; Epiney, Jean-Benoit; Vijiala, Sergiu; Salvioni-Chiabotti, Paolo; Anichini, Angelica; Salerno, Alexander; Jaton, Katia; Vaucher, Julien; Perreau, Matthieu; Greub, Gilbert;... Journal: Neurology Issue: Volume 8:Issue 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Increased ex vivo antigen presentation profile of B cells in multiple sclerosis. (May 2017) Authors: Mathias, Amandine; Perriard, Guillaume; Canales, Mathieu; Soneson, Charlotte; Delorenzi, Mauro; Schluep, Myriam; Du Pasquier, Renaud A Journal: Multiple sclerosis Issue: Volume 23:Number 6(2017) Page Start: 802 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The VZV/IE63-specific T cell response prevents herpes zoster in fingolimod-treated patients. Issue 2 (April 2016) Authors: Mathias, Amandine; Perriard, Guillaume; Canales, Mathieu; Vuilleumier, Fanny; Perrotta, Gaetano; Schluep, Myriam; Du Pasquier, Renaud Journal: Neurology Issue: Volume 3:Issue 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity. (October 2016) Authors: Kuhle, Jens; Barro, Christian; Disanto, Giulio; Mathias, Amandine; Soneson, Charlotte; Bonnier, Guillaume; Yaldizli, Özguer; Regeniter, Axel; Derfuss, Tobias; Canales, Mathieu; Schluep, Myriam; Du Pasquier, Renaud; Krueger, Gunnar; Granziera, Cristina Journal: Multiple sclerosis Issue: Volume 22:Number 12(2016) Page Start: 1550 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Ocrelizumab Impairs the Phenotype and Function of Memory CD8+ T Cells: A 1-Year Longitudinal Study in Patients With Multiple Sclerosis. Issue 2 (30th March 2023) Authors: Mathias, Amandine; Pantazou, Vasiliki; Perriot, Sylvain; Canales, Mathieu; Jones, Samuel; Oberholster, Larise; Moulin, Michaël; Fenwick, Craig; Bernard-Valnet, Raphaël; Théaudin, Marie; Pot, Caroline; Du Pasquier, Renaud A. Journal: Neurology Issue: Volume 10:Issue 2(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Natalizumab treatment alters the expression of T-cell trafficking marker LFA-1 α-chain (CD11a) in MS patients. (June 2014) Authors: Jilek, Samantha; Mathias, Amandine; Canales, Mathieu; Lysandropoulos, Andreas; Pantaleo, Giuseppe; Schluep, Myriam; Du Pasquier, Renaud A Journal: Multiple sclerosis Issue: Volume 20:Number 7(2014) Page Start: 837 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impaired T-cell migration to the CNS under fingolimod and dimethyl fumarate. Issue 6 (November 2017) Authors: Mathias, Amandine; Perriot, Sylvain; Canales, Mathieu; Blatti, Claudia; Gaubicher, Coline; Schluep, Myriam; Engelhardt, Britta; Du Pasquier, Renaud Journal: Neurology Issue: Volume 4:Issue 6(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗